Wikidata

(Q65471955)

English

Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

clinical trial

In more languages

Statements

title
A Two Year Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Fracture Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Annually for the Treatment of Osteoporosis in Men (English)
0 references
sponsor
Novartis
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Denmark
0 references
Finland
0 references
Germany
0 references
Hungary
0 references
Iceland
0 references
Italy
0 references
Norway
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Slovakia
0 references
South Africa
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
United Kingdom
0 references
start time
December 2006
0 references
end time
October 2010
0 references
number of participants
1,199
0 references
research site
Novartis
0 references
minimum age
50 year
0 references
maximum age
85 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q65471955&oldid=1858465987"